Nisa Investment Advisors LLC decreased its stake in shares of Inspire Medical Systems, Inc. (NYSE:INSP – Get Rating) by 9.2% during the 1st quarter, Holdings Channel reports. The institutional investor owned 863 shares of the company’s stock after selling 87 shares during the period. Nisa Investment Advisors LLC’s holdings in Inspire Medical Systems were worth $222,000 at the end of the most recent reporting period.
Other large investors also recently added to or reduced their stakes in the company. Leverty Financial Group LLC acquired a new position in Inspire Medical Systems during the 4th quarter valued at about $25,000. Rockefeller Capital Management L.P. lifted its position in Inspire Medical Systems by 80.0% during the 4th quarter. Rockefeller Capital Management L.P. now owns 144 shares of the company’s stock valued at $33,000 after purchasing an additional 64 shares during the period. Covestor Ltd acquired a new position in Inspire Medical Systems during the 4th quarter valued at about $35,000. Pinebridge Investments L.P. acquired a new position in Inspire Medical Systems during the 4th quarter valued at about $46,000. Finally, Signaturefd LLC lifted its position in Inspire Medical Systems by 59.0% during the 4th quarter. Signaturefd LLC now owns 337 shares of the company’s stock valued at $78,000 after purchasing an additional 125 shares during the period. 93.98% of the stock is currently owned by institutional investors and hedge funds.
Inspire Medical Systems Stock Performance
Shares of NYSE:INSP opened at $208.37 on Thursday. The firm’s 50 day simple moving average is $187.28 and its 200 day simple moving average is $211.39. Inspire Medical Systems, Inc. has a fifty-two week low of $142.74 and a fifty-two week high of $286.29. The company has a debt-to-equity ratio of 0.06, a current ratio of 6.08 and a quick ratio of 5.57. The company has a market capitalization of $5.75 billion, a price-to-earnings ratio of -133.57 and a beta of 1.57.
Analyst Ratings Changes
A number of research firms have issued reports on INSP. Piper Sandler upped their target price on shares of Inspire Medical Systems from $305.00 to $310.00 in a research report on Wednesday, May 4th. Truist Financial cut their price target on shares of Inspire Medical Systems from $296.00 to $250.00 and set a “buy” rating on the stock in a research report on Friday, June 10th. TheStreet downgraded shares of Inspire Medical Systems from a “c-” rating to a “d+” rating in a research report on Friday, May 20th. Finally, Wolfe Research began coverage on shares of Inspire Medical Systems in a research report on Tuesday, April 5th. They issued a “market perform” rating and a $270.00 price target on the stock. One research analyst has rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $288.00.
Inspire Medical Systems Company Profile
Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.
- Get a free copy of the StockNews.com research report on Inspire Medical Systems (INSP)
- The MarketBeat Podcast: Portfolio Management in Market Downturns
- Can These Two Airline Stocks Overcome Gravity And Fly Higher?
- Shopify Stock Rallies Despite Quarterly Loss
- Two Automation Stocks The Institutions Are Buying
- Can Owens-Corning Insulate Your Portfolio?
Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.